These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 6275986)

  • 1. Methotrexate in the chemotherapy of lung cancer.
    Smyth JF; Ford HT
    Cancer Treat Rep; 1981; 65 Suppl 1():161-3. PubMed ID: 6275986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upper hemibody and local chest irradiation as consolidation following response to high-dose induction chemotherapy for small cell bronchogenic carcinoma--a pilot study.
    Mason BA; Richter MP; Catalano RB; Creech RB
    Cancer Treat Rep; 1982 Aug; 66(8):1609-12. PubMed ID: 6286119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
    Cohen MH; Ihde DC; Bunn PA; Fossieck BE; Matthews MJ; Shackney SE; Johnston-Early A; Makuch R; Minna JD
    Cancer Treat Rep; 1979 Feb; 63(2):163-70. PubMed ID: 221114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
    Aisner J; Whitacre M; Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer.
    Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
    Cancer Treat Rep; 1982 Dec; 66(12):2005-11. PubMed ID: 6291763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.
    Newman SB; DeMeester TR; Golomb HM; Hoffman PC; Little AG; Raghavan V
    J Thorac Cardiovasc Surg; 1983 Aug; 86(2):180-5. PubMed ID: 6308356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive chemotherapy of small cell bronchogenic carcinoma.
    Cohen MH; Creaven PJ; Fossieck BE; Broder LE; Selawry OS; Johnston AV; Williams CL; Minna JD
    Cancer Treat Rep; 1977; 61(3):349-54. PubMed ID: 194691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide, vincristine, lomustine, cisplatin, and doxorubicin in the treatment of non-small cell lung cancer.
    Pearlman NW; Meyers TJ; Siebert PE; Wallner SF; Carson SD; Campbell DN; Johnson FB; Kennaugh R; Rempel P
    Cancer Treat Rep; 1983 Apr; 67(4):375-6. PubMed ID: 6303587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-drug chemotherapy combined with radiation therapy in small cell carcinoma of the lung.
    Sibille Y; Steyaert J; Francis C; Bosly A; Prignot J
    Eur J Respir Dis; 1983 Feb; 64(2):113-20. PubMed ID: 6299770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive induction treatment of small cell bronchogenic carcinoma with cyclophosphamide, methotrexate, and etoposide.
    Bonomi P; O'Reilly W; Vogl SE; Ruckdeschel JC; Stolbach L; Bunting N; Creech RH
    Cancer Treat Rep; 1985 Sep; 69(9):1007-9. PubMed ID: 2992783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-agent and combination chemotherapy for extensive non-small cell carcinomas of the lung.
    Davis S; Pandya MR; Rambotti P
    Cancer Treat Rep; 1980; 64(4-5):685-8. PubMed ID: 6253067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma.
    Poplin EA; Aisner J; Van Echo DA; Whitacre M; Wiernik PH
    Cancer Treat Rep; 1982 Jul; 66(7):1557-9. PubMed ID: 6284360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.
    Vogelzang NJ; Trowbridge RC; Frenning DH; Theologides A; Kennedy BJ; Kelly DR; Ewing SL; Vosika GJ
    Cancer Treat Rep; 1980; 64(8-9):997-1000. PubMed ID: 6256076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.
    Chahinian PA; Arnold DJ; Cohen JM; Purpora DP; Jaffrey IS; Teirstein AS; Kirschner PA; Holland JF
    JAMA; 1977 May; 237(22):2392-6. PubMed ID: 576939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD; Greco FA
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for inoperable, non-small cell bronchogenic carcinoma: EST 2575, generation II.
    Ruckdeschel JC; Mehta CR; Salazar OM; Cohen M; Vogl S; Koons LS; Lerner H
    Cancer Treat Rep; 1981; 65(11-12):965-72. PubMed ID: 7028258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor size, response rate, and prognosis in small cell carcinoma of the bronchus treated by combination chemotherapy.
    Harper PG; Souhami RL; Spiro SG; Geddes DM; Guimaraes M; Fearon F; Smyth JF
    Cancer Treat Rep; 1982 Mar; 66(3):463-70. PubMed ID: 6277486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adriamycin in the combined chemotherapy of small-cell lung cancer].
    Perevodchikova NI; Bychkov MB; Ausekar BV
    Antibiotiki; 1983 Aug; 28(8):628-32. PubMed ID: 6314882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small cell anaplastic carcinoma of the lung. The Cancer and Leukemia Group B Experience.
    Chahinian AP; Comis RL; Maurer LH; Pajak TF
    Bull Cancer; 1982; 69(1):79-82. PubMed ID: 6280794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the results of chemotherapy in squamous cell bronchial carcinoma].
    Nagorni-Obradović L
    Med Pregl; 1991; 44(9-10):387-90. PubMed ID: 1806789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.